Fibroma other imaging findings

Jump to navigation Jump to search

Fibroma Microchapters


Patient Information


Historical Perspective




Epidemiology and Demographics

Risk Factors


Differentiating Fibroma from other Diseases

Natural History, Complications & Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

X Ray




Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Case Studies

Case #1

Fibroma other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Fibroma other imaging findings

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibroma other imaging findings

CDC on Fibroma other imaging findings

Fibroma other imaging findings in the news

Blogs on Fibroma other imaging findings

Directions to Hospitals Treating Fibroma

Risk calculators and risk factors for Fibroma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2], Simrat Sarai, M.D. [3]


Other imaging studies for ossifying fibroma include bone scan, which demonstrates mild hyperemia and moderate bone uptake during healing. However, in general they are negative.

Other Imaging Findings

Bone Scan

Ossifying Fibroma

Appearance of ossifying fibroma depends on the phase of the lesion. In general they are negative; however, mild hyperaemia and moderate bone uptake are present during healing. If extensive uptake or hyperaemia are present, then an alternative diagnosis or superimposed fracture should be considered.

Non ossifying fibroma

They are metabolically active on F18-FDG-PET images.That activity, probably is independent of lesion size, varies among patients and over time, as indicated by their F18-FDG uptake on PET. [1][2][3]

Chondromyxoid Fibroma


  1. Pagano M, Berta M, Postini AM, Bianchi M, Del Prever AB, Defilippi C, Ficola U, Cistaro A (2011). "Nonossifying fibroma: A possible pitfall in F18-FD-PET/CT imaging of Hodgkin's disease". Radiol Case Rep. 6 (2): 271. doi:10.2484/rcr.v6i2.271. PMC 4901151. PMID 27307893.
  2. Betsy M, Kupersmith LM, Springfield DS (2004). "Metaphyseal fibrous defects". J Am Acad Orthop Surg. 12 (2): 89–95. PMID 15089082.
  3. Goodin GS, Shulkin BL, Kaufman RA, McCarville MB (October 2006). "PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease". AJR Am J Roentgenol. 187 (4): 1124–8. doi:10.2214/AJR.06.0171. PMID 16985165.
  4. Hamada, Kenichiro; Tomita, Yasuhiko; Konishi, Eiichi; Fujimoto, Tetsuho; Jin, Yu Fen; Outani, Hidetatsu; Tamiya, Hironari; Naka, Norifumi; Araki, Nobuhito (2009). "FDG-PET Evaluation of Chondromyxoid Fibroma of Left Ilium". Clinical Nuclear Medicine. 34 (1): 15–17. doi:10.1097/RLU.0b013e31818f464b. ISSN 0363-9762.
  5. Makis, William; Ciarallo, Anthony; Lisbona, Robert (2011). "Chondromyxoid fibroma of the rib mimics a chondrosarcoma on 18F-FDG PET/CT". Acta Radiologica. 52 (5): 554–556. doi:10.1258/ar.2011.100526. ISSN 0284-1851.
  6. Subhawong, Ty K.; Winn, Aaron; Shemesh, Shai S.; Pretell-Mazzini, Juan (2017). "F-18 FDG PET differentiation of benign from malignant chondroid neoplasms: a systematic review of the literature". Skeletal Radiology. 46 (9): 1233–1239. doi:10.1007/s00256-017-2685-7. ISSN 0364-2348.

Template:WikiDoc Sources